查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
功能服务供应商(FSP)市场:各服务形式，各治疗领域，各终端用户，不同企业规模，各地区-2023年～2030年的市场规模，占有率，展望，机会分析
市场调查报告书
商品编码
1330225

功能服务供应商(FSP)市场:各服务形式，各治疗领域，各终端用户，不同企业规模，各地区-2023年～2030年的市场规模，占有率，展望，机会分析

Functional Service Providers Market, By Service Type, By Therapeutic Area, By End-User, By Company Size, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格
简介目录

称为功能服务提供者 (FSP) 的专业公司为製药、生物技术和医疗器材产业提供外包服务。FSP 致力于提供支援服务的专业功能知识，包括临床研究、资料管理、监管事务、药物警戒和其他领域。FSP 与客户合作，在药物研究和商业化关键领域加强内部能力、简化流程并最大限度地提高效率。

市场动态：

临床试验外包的增加、试验复杂性、成本和营运效率的提高以及全球人才库的获取预计将在预测期内推动全球功能服务提供者（FSP）市场的成长。这是预期的主要因素。

但是，成本压力、人力和资源限制以及监管和合规复杂性预计将阻碍预测期内全球功能服务提供者 (FSP) 市场的成长。预计这将阻碍预测期内功能服务提供者（FSP）市场的成长。

本调查的主要特征

  • 本报告提供以2022年为基准年的预测期间（2023-2030 年）之全球功能服务供应商(FSP)市场的市场规模和復合年增长率（CAGR %）相关的详区隔析。
  • 并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
  • 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
  • 并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球功能服务供应商(FSP)市场的主要参与者之企业简介。
  • 藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 全球功能服务供应商(FSP)市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以透过全球功能服务供应商(FSP)市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查目的与前提条件

  • 调查目的
  • 前提条件
  • 简称

第2章 市场概况

  • 报告概要
    • 市场定义和范围
  • 摘要整理
  • Coherent Opportunity Map(COM)

第3章 市场动态，法规，趋势分析

  • 市场动态
    • 临床试验外包增加
    • 成本压力、人力与资源限制
    • 接触全球人才库
  • 影响分析
  • 主要的焦点
  • 法规惰势
  • 产品上市/核准
  • PEST分析
  • 波特分析
  • 合併·收购惰势

第4章 功能服务供应商(FSP)的全球市场-冠状病毒(COVID-19)流行的影响

  • COVID-19流行病学
  • 供给面和需求面的分析
  • 经济影响

第5章 功能服务供应商(FSP)的全球市场:各服务形式，2023-2030年

  • 临床试验设计和管理
  • 数据管理与生物统计
  • 药事
  • 医学写作
  • 药物安全检测和医药品安全性
  • 品质保证和遵守
  • 临床实验设施管理和监测
  • 患者征聘和留任
  • 其他的服务

第6章 功能服务供应商(FSP)的全球市场:各治疗领域，2023年～2030年

  • 癌症领域
  • 循环系统
  • 感染疾病
  • 中枢神经系统(CNS)
  • 呼吸系统
  • 免疫学
  • 消化器官
  • 其他的治疗领域

第7章 功能服务供应商(FSP)的全球市场:各终端用户，2023-2030年

  • 製药企业
  • 生物科技企业
  • CRO(医药品临床研究委外机构)
  • 学术·研究机关
  • 医疗设备厂商
  • 其他终端用户

第8章 功能服务供应商(FSP)的全球市场:不同企业规模，2023-2030年

  • 中小企业(SMEs)
  • 大企业

第9章 功能服务供应商(FSP)的全球市场:各地区，2023-2030年

  • 北美
  • 欧洲
  • 亚太地区
  • 南美
  • 中东·非洲

第10章 竞争情形

  • QuintilesIMS(now IQVIA)
  • Parexel International Corporation
  • ICON plc
  • PRA Health Sciences
  • Covance Inc.
  • Charles River Laboratories International Inc.
  • Syneos Health
  • Pharmaceutical Product Development, LLC(PPD)
  • Medpace Holdings, Inc
  • LabCorp(Laboratory Corporation of America Holdings)
  • Wuxi AppTec
  • inVentiv Health(now Syneos Health)
  • PAREXEL International(now part of PPD)
  • Accenture
  • Cognizant

第11章 章节

  • 调查手法
  • 关于出版社
简介目录
Product Code: CMI5962

Specialized businesses called Functional Service Providers (FSPs) provide outsourced services to the pharmaceutical, biotechnology, and medical device sectors. FSPs concentrate on offering specialized functional knowledge in support services including clinical research, data administration, regulatory affairs, pharmacovigilance, and other areas. In order to enhance internal capabilities, streamline processes, and maximize efficiency in areas crucial to medication research and commercialization, they collaborate with their clients.

Market Dynamics:

Increasing outsourcing of clinical trials, growing complexity of trials, cost and operational efficiency, and access to a global talent pool are major factors expected to drive growth of the global functional service providers (FSP) market during the forecast period.

However, cost pressures, talent and resource constraints, and regulatory and compliance complexities. Are expected to hamper the growth of the functional service providers (FSP) market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global functional service providers (FSP) market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global functional service providers (FSP) market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Major players operating in the functional service providers FSP market include QuintilesIMS (now IQVIA), Parexel International Corporation, ICON plc, PRA Health Sciences, Covance Inc., Charles River Laboratories International Inc., Syneos Health, and more.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global functional service providers (FSP) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global functional service providers (FSP) market.

Detailed Segmentation:

  • Global Functional Service Providers (FSP) Market, By Service Type:
    • Clinical Trial Design and Management
    • Data Management and Biostatistics
    • Regulatory Affairs
    • Medical Writing
    • Pharmacovigilance and Drug Safety
    • Quality Assurance and Compliance
    • Site Management and Monitoring
    • Patient Recruitment and Retention
    • Other Services
  • Global Functional Service Providers (FSP) Market, By Therapeutic Area:
    • Oncology
    • Cardiovascular
    • Infectious Diseases
    • Central Nervous System (CNS)
    • Respiratory
    • Immunology
    • Gastrointestinal
    • Other Therapeutic Areas
  • Global Functional Service Providers (FSP) Market, By End-User:
    • Pharmaceutical Companies
    • Biotechnology Companies
    • Contract Research Organizations (CROs)
    • Academic and Research Institutes
    • Medical Device Companies
    • Other End-Users
  • Global Functional Service Providers (FSP) Market, By Company Size:
    • Small and Medium-sized Enterprises (SMEs)
    • Large Enterprises
  • Global Functional Service Providers (FSP) Market, By Geography:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles:
    • QuintilesIMS (now IQVIA)
    • Parexel International Corporation
    • ICON plc
    • PRA Health Sciences
    • Covance Inc.
    • Charles River Laboratories International Inc.
    • Syneos Health
    • Pharmaceutical Product Development, LLC (PPD)
    • Medpace Holdings, Inc.
    • LabCorp (Laboratory Corporation of America Holdings)
    • Wuxi AppTec
    • inVentiv Health (now Syneos Health)
    • PAREXEL International (now part of PPD)
    • Accenture
    • Cognizant

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Service Type
    • Market Snapshot, By Therapeutic Area
    • Market Snapshot, By End User
    • Market Snapshot, By Company Size
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing outsourcing of clinical trials
    • Cost pressures, talent and resource constraints,
    • Access to a global talent pool
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Functional Service Providers (FSP) Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Functional Service Providers (FSP) Market, By Service Type, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Clinical Trial Design and Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Data Management and Biostatistics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Regulatory Affairs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Medical Writing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Pharmacovigilance and Drug Safety
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Quality Assurance and Compliance
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Site Management and Monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Patient Recruitment and Retention
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Other Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

6. Global Functional Service Providers (FSP) Market, By Therapeutic Area, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Central Nervous System (CNS)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Respiratory
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Immunology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Gastrointestinal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Other Therapeutic Areas
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

7. Global Functional Service Providers (FSP) Market, By End User, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Medical Device Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Other End-Users
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

8. Global Functional Service Providers (FSP) Market, By Company Size, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Small and Medium-sized Enterprises (SMEs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Large Enterprises
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

9. Global Functional Service Providers (FSP) Market, By Geography, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2023-2030,(US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2023-2030,(US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2023-2030,(US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2023-2030,(US$ Bn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2023-2030,(US$ Bn)

10. Competitive Landscape

  • QuintilesIMS (now IQVIA)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Parexel International Corporation
  • ICON plc
  • PRA Health Sciences
  • Covance Inc.
  • Charles River Laboratories International Inc.
  • Syneos Health
  • Pharmaceutical Product Development, LLC (PPD)
  • Medpace Holdings, Inc
  • LabCorp (Laboratory Corporation of America Holdings)
  • Wuxi AppTec
  • inVentiv Health (now Syneos Health)
  • PAREXEL International (now part of PPD)
  • Accenture
  • Cognizant
  • Analyst Views

11. Section

  • Research Methodology
  • About us